Controllable fusion of human brain organoids using acoustofluidics

Zheng Ao(Shanghai Ninth People's Hospital), Feng Guo(Indiana University Health), Huiliang Wang(The University of Texas at Austin), Hongwei Cai(China Academy of Launch Vehicle Technology), Zhuhao Wu(Wuhan University), Jonathan Ott(Bloomington Health Foundation), Ken Mackie(Indiana University Bloomington)
Lab on a Chip
January 1, 2021
10.1039/d0lc01141j
Cited by 97

Related Papers

A skin-inspired organic digital mechanoreceptor
|Science|2015|856
JWH018, a common constituent of ‘Spice’ herbal blends, is a potent and efficacious cannabinoid CB<sub>1</sub>receptor agonist
|British Journal of Pharmacology|2010|260
CB2 Cannabinoid Receptors as a Therapeutic Target—What Does the Future Hold?
|Molecular Pharmacology|2014|257
Parsing the players: 2‐arachidonoylglycerol synthesis and degradation in the<scp>CNS</scp>
|British Journal of Pharmacology|2013|251
Functional Selectivity in CB2 Cannabinoid Receptor Signaling and Regulation: Implications for the Therapeutic Potential of CB2 Ligands
|Molecular Pharmacology|2011|152